Markets:

Overview

News

Currencies

International

Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

108.81 -2.44 (-2.19%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

The market is filled with gapping stocks in Thursday's session. ↗

October 30, 2025

Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗

October 30, 2025

Via Benzinga

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

October 30, 2025

The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

Earnings Scheduled For October 29, 2025 ↗

October 29, 2025

Via Benzinga

GH Q3 Deep Dive: Broad-Based Growth, Screening Momentum, and Margin Improvement

October 30, 2025

Diagnostics company Guardant Health (NASDAQ:GH) announced better-than-expected revenue in Q3 CY2025, with sales up 38.5% year on year to $265.2 million. The company’s full-year revenue guidance of...

Via StockStory

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 30, 2025

Via Benzinga

Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 30, 2025

Via Benzinga

Guardant Health Stock Soars 21% After-Hours As Strong Q3, Raised Guidance Spark Retail Frenzy ↗

October 30, 2025

Guardant Health’s Q3 revenue surged 39% year-over-year to $265.2 million, led by strong growth in its oncology, screening, and biopharma segments.

Via Stocktwits

What's going on in today's after hours session ↗

October 29, 2025

The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

Guardant Health (GH) Q3 2025 Earnings Transcript ↗

October 29, 2025

Guardant Health (GH) Q3 2025 Earnings Transcript

Via The Motley Fool

Topics Earnings

Guardant Health’s (NASDAQ:GH) Q3: Strong Sales, Stock Jumps 15.5%

October 29, 2025

Diagnostics company Guardant Health (NASDAQ:GH) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 38.5% year on year to $265.2 million. The company’s full-year revenue...

Via StockStory

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 29, 2025

Via Benzinga

Why IBD 50's Guardant Health, Up 137% in 2025, Could Surge Again ↗

October 29, 2025

Shares could rocket, again, Wednesday after the diagnostics company smashed Wall Street's third-quarter calls.

Via Investor's Business Daily

Topics Earnings

Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

October 29, 2025

From Guardant Health, Inc.

Via Business Wire

Earnings To Watch: Guardant Health (GH) Reports Q3 Results Tomorrow

October 27, 2025

Diagnostics company Guardant Health (NASDAQ:GH) will be announcing earnings results this Wednesday after the bell. Here’s what investors should know.

Via StockStory

Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights

October 27, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025

October 26, 2025

From Guardant Health, Inc.

Via Business Wire

Is Guardant Health Inc Gaining or Losing Market Support? ↗

October 21, 2025

Via Benzinga

Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025

October 15, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025

October 09, 2025

From Guardant Health, Inc.

Via Business Wire

1 Volatile Stock to Research Further and 2 Facing Headwinds

October 07, 2025

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Via StockStory

Topics Initial Public Offering

What Does the Market Think About Guardant Health Inc? ↗

October 03, 2025

Via Benzinga

Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures

October 02, 2025

A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human...

Via MarketMinute

Topics Artificial Intelligence Derivatives

Stocks making big moves yesterday: Beyond Meat, The Trade Desk, Guardant Health, PayPal, and Tilray

September 30, 2025

Check out the companies making headlines yesterday:

Via StockStory

Topics Cannabis Government

Why Guardant Health (GH) Stock Is Trading Up Today

September 29, 2025

Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.6% in the morning session after the U.S. Food and Drug Administration (FDA) approved its Guardant360® CDx blood test as a companion...

Via StockStory

FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer

September 29, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health (GH) Stock Trades Up, Here Is Why

September 25, 2025

Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 5.2% in the morning session after the company announced a collaboration with Quest Diagnostics and provided an upbeat financial outlook...

Via StockStory

Topics Artificial Intelligence

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States

September 24, 2025

From Guardant Health, Inc.

Via Business Wire

3 Reasons to Avoid GH and 1 Stock to Buy Instead

September 24, 2025

Guardant Health’s 28.8% return over the past six months has outpaced the S&P 500 by 13.3%, and its stock price has climbed to $60.20 per share. This was partly due to its solid quarterly results, and...

Via StockStory

Topics Bankruptcy Stocks

Guardant Health (GH) Stock Is Up, What You Need To Know

September 23, 2025

Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.2% in the afternoon session after multiple financial analysts issued positive ratings on the stock. Canaccord Genuity reaffirmed its...

Via StockStory

Topics Artificial Intelligence Economy

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Guardant Health, Inc. - Common Stock (NQ:GH)

All News about Guardant Health, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today